Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: ADVAGRAF
Active substances:
Estonian, English, Latin
ATC code: L04AD02
Dosage form: prolonged-release capsule, hard
Strength: 1mg
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Indication: Prophylaxis of transplant rejection in adult kidney or liver allograft recipients. Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.
Safety features: Yes
Marketing authorization holder: Astellas Pharma Europe B.V. 
Marketing authorization number: EU/1/07/387 
Marketing authorization issued on: April 23, 2007 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1294679  ADVAGRAF  prolonged-release capsule, hard  1mg 30TK  Prescription           
1294680  ADVAGRAF  prolonged-release capsule, hard  1mg 50TK  Prescription  100%  37,00  01.02.2023     
1294691  ADVAGRAF  prolonged-release capsule, hard  1mg 60TK  Prescription           
1294703  ADVAGRAF  prolonged-release capsule, hard  1mg 100TK  Prescription      17.09.2015     
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere